Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

13 Oct 2025 13:33

RNS Number : 1450D
Savills PLC
13 October 2025
 

SAVILLS PLC (THE "COMPANY")

ALLOCATION OF SHARES UNDER THE SAVILLS SHARE INCENTIVE PLANNOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Savills Share Incentive Plan ("the Plan") is a share purchase plan available to all employees of participating companies and Executive Directors/ PDMRs are eligible to participate. Each month the Trustees of the Plan invest participants' contributions in Savills plc ordinary shares of 2.5p each ("Ordinary Shares") at the prevailing market price in accordance with the Plan Rules. 

The Company has been advised by the Trustees of the Plan that on 10 October 2025, Ordinary Shares were allocated at £9.8768 per share to the following PDMR of Savills plc who is a participant in the Plan:

PDMR

Number of Ordinary Shares allocated 10 October 2025

Number of Ordinary Shares held in the Plan following October's allocation

Total beneficial interest in Savills plc ordinary shares of 2.5p each

James Sparrow

15

6,323

125,654

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

James Sparrow

 

2.

Reason for the notification

 

(a)

Position/ status

CEO, Savills UK & CEME/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Purchase of Ordinary Shares through the Savills Share Incentive Plan

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£9.8768

 

15

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

10 October 2025

(g)

Place of the transaction

 

London Stock Exchange (XLON)

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

13 October 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMMGZFGGKZM
Date   Source Headline
14th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20208:59 amRNSNon-executive Director changes
14th Dec 20209:45 amRNSDirector/PDMR Shareholding
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
3rd Nov 20202:26 pmRNSHolding(s) in Company
22nd Oct 20205:41 pmRNSHolding(s) in Company
13th Oct 20205:22 pmRNSDirector/PDMR Shareholding
1st Oct 202010:00 amRNSTotal Voting Rights
14th Sep 202011:05 amRNSDirector/PDMR Shareholding
2nd Sep 202010:41 amRNSHolding(s) in Company
13th Aug 20205:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSHalf-year Report
4th Aug 20203:22 pmRNSTotal Voting Rights
21st Jul 202010:00 amRNSBlock listing Interim Review
13th Jul 20202:15 pmRNSHolding(s) in Company
13th Jul 202012:26 pmRNSDirector/PDMR Shareholding
6th Jul 202010:13 amRNSHolding(s) in Company
6th Jul 202010:09 amRNSHolding(s) in Company
1st Jul 20204:51 pmRNSDirector/PDMR Shareholding
1st Jul 202010:00 amRNSTotal Voting Rights
30th Jun 20204:52 pmRNSDirector/PDMR Shareholding
25th Jun 202011:27 amRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
11th Jun 202011:29 amRNSDirector/PDMR Shareholding
5th Jun 20201:03 pmRNSDirectors Remuneration Policy - Clarification
5th Jun 202012:42 pmRNSDirectors Remuneration Policy - Clarification
1st Jun 20207:00 amRNSTotal Voting Rights
12th May 202012:01 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 202012:15 pmRNSDisclosure of rights attached to equity shares
28th Apr 20203:53 pmRNSDirector/PDMR Shareholding
16th Apr 202011:56 amRNSDirector/PDMR Shareholding
6th Apr 202012:37 pmRNSAnnual Report and AGM Notice
1st Apr 20207:00 amRNS2020 AGM & 2019 final and supplemental dividends
1st Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20205:33 pmRNSDirector/PDMR Shareholding
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.